These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 16731112)

  • 21. Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era.
    Kimura T; Morimoto T; Furukawa Y; Nakagawa Y; Shizuta S; Ehara N; Taniguchi R; Doi T; Nishiyama K; Ozasa N; Saito N; Hoshino K; Mitsuoka H; Abe M; Toma M; Tamura T; Haruna Y; Imai Y; Teramukai S; Fukushima M; Kita T
    Circulation; 2008 Sep; 118(14 Suppl):S199-209. PubMed ID: 18824755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.
    Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Choo SJ; Song H; Chung CH; Lee JW; Park SW; Park SJ
    Circulation; 2008 Apr; 117(16):2079-86. PubMed ID: 18413495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major adverse cardiac events at follow-up after bare-metal stenting versus drug-eluting stenting in ST-elevated myocardial infarction.
    Pierre-Louis B; Aronow WS; Palaniswamy C; Singh T; Ahn C; Asija A; Weiss MB; Kalapatapu K; Pucillo AL; Monsen CE
    Am J Cardiol; 2009 Jun; 103(12):1672-4. PubMed ID: 19539074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of systematic reviews on invasive treatment of stable coronary artery disease.
    Kuukasjärvi P; Malmivaara A; Halinen M; Hartikainen J; Keto PE; Talvensaari T; Tierala I; Mäkelä M
    Int J Technol Assess Health Care; 2006; 22(2):219-34. PubMed ID: 16571198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated coronary revascularization: percutaneous coronary intervention plus robotic totally endoscopic coronary artery bypass.
    Katz MR; Van Praet F; de Canniere D; Murphy D; Siwek L; Seshadri-Kreaden U; Friedrich G; Bonatti J
    Circulation; 2006 Jul; 114(1 Suppl):I473-6. PubMed ID: 16820621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.
    Mack MJ; Prince SL; Herbert M; Brown PP; Katz M; Palmer G; Edgerton JR; Eichhorn E; Magee MJ; Dewey TM
    Ann Thorac Surg; 2008 Aug; 86(2):496-503; discussion 503. PubMed ID: 18640323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome after coronary artery bypass graft surgery, coronary angioplasty and stenting.
    Völzke H; Henzler J; Menzel D; Robinson DM; Hoffmann W; Vogelgesang D; John U; Motz W; Rettig R
    Int J Cardiol; 2007 Mar; 116(1):46-52. PubMed ID: 16822561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
    Yang ZK; Shen WF; Zhang RY; Kong Y; Zhang JS; Hu J; Zhang Q; Ding FH
    J Interv Cardiol; 2007 Feb; 20(1):10-6. PubMed ID: 17300391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of off-pump coronary artery bypass grafting with percutaneous coronary intervention versus drug-eluting stents for three-vessel coronary artery disease.
    Yi G; Youn YN; Yoo KJ; Hong YS
    Ann Thorac Surg; 2008 Nov; 86(5):1438-43. PubMed ID: 19049727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Does diabetes change the anti-ischemic therapeutic options in the symptomatic coronary patient?].
    Bory M
    Arch Mal Coeur Vaiss; 2000 Dec; 93 Spec No 4():45-50. PubMed ID: 11296462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.
    Rossini R; Angiolillo DJ; Musumeci G; Scuri P; Invernizzi P; Bass TA; Mihalcsik L; Gavazzi A
    Am J Cardiol; 2008 Mar; 101(6):786-9. PubMed ID: 18328841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions.
    Jeger RV; Schneiter S; Kaiser C; Bonetti PO; Brunner-La Rocca H; Handke M; Osswald S; Buser PT; Pfisterer ME;
    Cardiology; 2009; 112(1):49-55. PubMed ID: 18580059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.
    Hlatky MA; Boothroyd DB; Melsop KA; Brooks MM; Mark DB; Pitt B; Reeder GS; Rogers WJ; Ryan TJ; Whitlow PL; Wiens RD
    Circulation; 2004 Oct; 110(14):1960-6. PubMed ID: 15451795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-eluting stents and the future of coronary artery bypass surgery: facts and fiction.
    Raja SG
    Ann Thorac Surg; 2006 Mar; 81(3):1162-71. PubMed ID: 16488758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis.
    Nordmann AJ; Briel M; Bucher HC
    Eur Heart J; 2006 Dec; 27(23):2784-814. PubMed ID: 17020889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
    Boyden TF; Nallamothu BK; Moscucci M; Chan PS; Grossman PM; Tsai TT; Chetcuti SJ; Bates ER; Gurm HS
    Am J Cardiol; 2007 May; 99(10):1399-402. PubMed ID: 17493468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up.
    Roukoz H; Bavry AA; Sarkees ML; Mood GR; Kumbhani DJ; Rabbat MG; Bhatt DL
    Am J Med; 2009 Jun; 122(6):581.e1-10. PubMed ID: 19486720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of complete revascularization on 10-year survival of patients with stable multivessel coronary artery disease: MASS II trial.
    Vieira RD; Hueb W; Gersh BJ; Lima EG; Pereira AC; Rezende PC; Garzillo CL; Hueb AC; Favarato D; Soares PR; Ramires JA; Kalil Filho R
    Circulation; 2012 Sep; 126(11 Suppl 1):S158-63. PubMed ID: 22965977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.
    Kim YH; Park DW; Lee SW; Yun SC; Lee CW; Hong MK; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ;
    Circulation; 2009 Aug; 120(5):400-7. PubMed ID: 19620506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.